121 related articles for article (PubMed ID: 6358985)
21. Structural difference in the complement activation site of human IgG1 and IgG3.
Michaelsen TE; Sandlie I; Bratlie DB; Sandin RH; Ihle O
Scand J Immunol; 2009 Dec; 70(6):553-64. PubMed ID: 19906198
[TBL] [Abstract][Full Text] [Related]
22. Rapid three-step purification procedure for isolation of the C1q component of human complement and its use in a solid-phase C1q binding assay.
Bähr EA; Drahovsky D
J Immunol Methods; 1984 Apr; 69(1):43-50. PubMed ID: 6325543
[TBL] [Abstract][Full Text] [Related]
23. Measurement of circulating immune complexes in human sera by enzyme immunoassay.
Cheung K; O'Kane D; Robinson MF
Aust J Exp Biol Med Sci; 1982 Dec; 60(6):593-605. PubMed ID: 6820632
[TBL] [Abstract][Full Text] [Related]
24. Detection of IgA-class circulating immune complexes (CIC) in sera from patients with IgA nephropathy using a solid-phase anti-C3 Facb enzyme immunoassay (EIA).
Yagame M; Tomino Y; Miura M; Tanigaki T; Suga T; Nomoto Y; Sakai H
Clin Exp Immunol; 1987 Feb; 67(2):270-6. PubMed ID: 3301093
[TBL] [Abstract][Full Text] [Related]
25. Circulating immune complexes in idiopathic glomerular disease.
Cairns SA; London RA; Mallick NP
Kidney Int; 1982 Mar; 21(3):507-12. PubMed ID: 6979654
[TBL] [Abstract][Full Text] [Related]
26. An assay for antigen-antibody complexes in human sera using C1q-enzyme conjugates.
Stimson WH; McAdam A; Hutchison RS
J Clin Lab Immunol; 1981 Mar; 5(2):129-31. PubMed ID: 7012357
[TBL] [Abstract][Full Text] [Related]
27. [Circulating immune complexes in breast cancer].
Abecassis J; Petit JC; Eber M; Klein T; Rodier D; Janser JC; Methlin G
Bull Cancer; 1985; 72(1):42-7. PubMed ID: 3872691
[TBL] [Abstract][Full Text] [Related]
28. The detection of complement binding immune complexes by means of 51Cr-labelled indicator cells.
Varga A; Kasper M; Stosiek P
Allerg Immunol (Leipz); 1986; 32(3):205-14. PubMed ID: 2947445
[TBL] [Abstract][Full Text] [Related]
29. Analysis of IgG immune complexes in sera from patients with membranous nephropathy: role of IgG4 subclass and low-avidity antibodies.
Doi T; Kanatsu K; Mayumi M; Hamashima Y; Yoshida H
Nephron; 1991; 57(2):131-6. PubMed ID: 2020338
[TBL] [Abstract][Full Text] [Related]
30. Correlation between circulating antigens detected by the radioimmunoprecipitation-polyethylene glycol assay (RIPEGA) and C1q-binding immune complexes in human schistosomiasis mansoni.
Santoro F; Prata A; Silva AE; Capron A
Am J Trop Med Hyg; 1981 Sep; 30(5):1020-5. PubMed ID: 6974508
[TBL] [Abstract][Full Text] [Related]
31. C1q microtiter plate ELISA system for detecting circulating immune complexes and its application of testing the sera in neurological diseases.
Araga S; Irie H; Takahashi K
Jpn J Exp Med; 1984 Feb; 54(1):23-7. PubMed ID: 6384588
[TBL] [Abstract][Full Text] [Related]
32. Investigation of the recommended use of anti-Clq for reducing non-specific reactions in solid-phase C1q assays for circulating immune complexes.
Wainer EM; Schepers G; Schweizer K; Pusztai-Markos Z
J Immunol Methods; 1984 Jan; 66(1):193-5. PubMed ID: 6363550
[No Abstract] [Full Text] [Related]
33. Influence of serum complement and rheumatoid factor on detection of immune complexes by the C1q and monoclonal rheumatoid factor solid-phase assay.
Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
J Immunol Methods; 1984 Oct; 73(2):301-11. PubMed ID: 6436384
[TBL] [Abstract][Full Text] [Related]
34. Circulating immune complexes in cervical cancer patients as detected by C1q binding.
Chao KC; Liu CC; Ng HT; Hu CP; Chang CM
Proc Natl Sci Counc Repub China B; 1984 Jan; 8(1):50-3. PubMed ID: 6335756
[TBL] [Abstract][Full Text] [Related]
35. Binding of complement subcomponent C1q to mouse IgG1, IgG2a and IgG2b: a novel C1q binding assay.
Leatherbarrow RJ; Dwek RA
Mol Immunol; 1984 Apr; 21(4):321-7. PubMed ID: 6610105
[TBL] [Abstract][Full Text] [Related]
36. Circulating antigen-antibody complexes in onchocerciasis.
Steward MW; Sisley B; Mackenzie CD; El Sheikh H
Clin Exp Immunol; 1982 Apr; 48(1):17-24. PubMed ID: 6979445
[TBL] [Abstract][Full Text] [Related]
37. An enzyme-linked immunoassay for detection of IgG- and C3-containing circulating immune complexes: comparison with a radioimmunoassay and quantitation in patients with rheumatic diseases.
Panush RS; Somberg LB; Katz P; Longley S
Diagn Immunol; 1983; 1(4):288-94. PubMed ID: 6388973
[TBL] [Abstract][Full Text] [Related]
38. Estimation of immune complexes by a microplate-adapted C1q-Protein A enzyme-linked-immunosorbent-assay (C1q-PA-ELISA).
Bjerrum L; Glikmann G; Jensenius JC; Svehag SE
J Clin Lab Immunol; 1983 Jan; 10(1):53-8. PubMed ID: 6338238
[TBL] [Abstract][Full Text] [Related]
39. The use of solid phase Clq and horseradish peroxidase-conjugated goat anti-IgG for the detection of immune complexes in human serum.
Wehler C; Andrews JM; Bing DH
Mol Immunol; 1981 Mar; 18(3):157-62. PubMed ID: 6973690
[No Abstract] [Full Text] [Related]
40. IgG subclass antibody to Mycobacterium leprae 18,000 MW antigen is restricted to IgG1 and IgG3 in leprosy.
Hussain R; Dockrell HM; Chiang TJ
Immunology; 1994 Nov; 83(3):495-500. PubMed ID: 7835976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]